المؤلفون: M. Khubutia Sh., М. Хубутия Ш.

المصدر: Transplantologiya. The Russian Journal of Transplantation; № 1 (2011); 4 ; Трансплантология; № 1 (2011); 4 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2011-0-1

وصف الملف: application/pdf

Relation: https://www.jtransplantologiya.ru/jour/article/view/300/361; https://www.jtransplantologiya.ru/jour/article/view/300

الاتاحة: https://www.jtransplantologiya.ru/jour/article/view/300
https://doi.org/10.23873/2074-0506-2011-0-1-4

المؤلفون: M. Khubutia Sh., S. Gautier V., M. Paltsev A., A. Chuchalin G., S. Dzemeshkevich L., A. Chzhao V., M. Minina G., G. Sganga, S. Astanina U., Ya. Moisyuk G., M. Kaabak M., М. Хубутия Ш., С. Готье В., М. Пальцев А., А. Чучалин Г., С. Дземешкевич Л., А. Чжао В., М. Каабак М., Я. Мойсюк Г., С. Астанина Ю., Г. Сганга, М. Минина Г.

المصدر: Transplantologiya. The Russian Journal of Transplantation; № 4 (2012); 5-11 ; Трансплантология; № 4 (2012); 5-11 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2012-0-4

وصف الملف: application/pdf

Relation: https://www.jtransplantologiya.ru/jour/article/view/358/419; https://www.jtransplantologiya.ru/jour/article/view/358

الاتاحة: https://www.jtransplantologiya.ru/jour/article/view/358
https://doi.org/10.23873/2074-0506-2012-0-4-5-11

المؤلفون: M. Khubutia Sh., Y. Kovalenko A., A. Chugunov O., A. Chzhao V., K. Dzhagraev R., A. Salienko A., O. Andreytseva I., L. Donova V., М. Хубутия Ш., Ю. Коваленко А., А. Чугунов О., А. Чжао В., К. Джаграев Р., А. Салиенко А., О. Андрейцева И., Л. Донова В.

المصدر: Transplantologiya. The Russian Journal of Transplantation; № 3 (2012); 15-21 ; Трансплантология; № 3 (2012); 15-21 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2012-0-3

مصطلحات موضوعية: hepatocellular carcinoma, liver transplantation, survival, prognosis, recurrence, гепатоцеллюлярный рак, трансплантация печени, выживаемость, прогноз, рецидив

وصف الملف: application/pdf

Relation: https://www.jtransplantologiya.ru/jour/article/view/354/415; Accuracy of staging as a predictor for reccurence after liver transplantation for hepatocellular carcinoma / S. A. Shah [et al.] // Transplantation. – 2006. – Vol. 81. – p. 1633–1639.; Tumor recurrence following liver transplantation for hepatocellular carcinoma: role of tumor proliferation status / A. Marshall [et al.] // Liver Transpl. – 2010. – Vol. 16 (3). – p. 279–288.; Liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease era / D.M. Levi [et al.] // J.Am. Coll. Surg. – 2010. – Vol. 210. – p. 727–736.; Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22–year experience with 467 patients at UCLA / J.P. Duffy [et al.] // Ann. Surg. – 2007. – Vol. 246. – p. 502–509.; Todo, S. Living donor liver transplantation for adult patients with hepatocellular carcinoma / S. Todo, H. Furukawa // Ann. Surg. – 2004. – Vol. 240. – p. 451–461.; Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impct on long-term survival / R.T. Poon [et al.] // Ann. Surg. – 2007. – Vol. 245. – p. 51–58.; Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma / K.K. Lee [et al.] // J. Surg. Oncol. – 2010. – Vol. 101. – p. 47–53.; Llovet, J. M. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation / J. M. Llovet, J. Fuster, J. Bruix // Hepatology. – 1999. – Vol. 30. – p. 1434–1440.; Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis / V. Mazzaferro [et al.] // N. Engl. J. Med. – 1996. – Vol. 334. – p. 693–699.; Liver Transplantation for Hepatocellular Carcinoma: Defining the Impact of Using Extended Criteria Liver Allografts / M. E. Facciuto [et al.] // Transplantation. – 2011. – Vol. 92. – p. 446–452.; Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival / F.Y. Yao [et al.] // Hepatology. – 2001. – Vol. 33. – p. 1394–1403.; Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients / B. Ringe [et al.] // World J. Surg. – 1991. – Vol. 15. – p. 270–285.; Hepatic resection versus transplantation for hepatocellular carcinoma / S. Iwatsuki [et al.] // Ann. Surg. – 1991. – Vol. 214. – p. 221–229.; Surgical treatment of hepatocellular carcinoma in cirrhosis: liver resection or transplantation? / H. Bismuth [et al.] // Transplant. Proc. – 1993. – Vol. 25. – p. 1066–1067.; Lencioni, R. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma / R. Lencioni, J.M. Llovet // Sem. Liver Dis. – 2010. – Vol. 30 (1). – p. 52–60.; Proceedings of the 2010 International Consensus Conference on liver transplantation for HCC. 2–4 December 2010. – Zurich. http: // www.OLT4HCC.org.; Liver transplantation and recurrent hepatocellular carcinoma: predictive value of nodule size in a retrospective and explant study / A. Grasso [et al.] // Transplantation. – 2006. – Vol. 81 (11). – p. 1532–1541.; Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence / M. Vivarelli [et al.] // Ann Surg. – 2008. – Vol. 248 (5). – p. 857–862.; D'Amico, F. Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria / F. D’Amico, M. Schwartz, A. Vitale // Liver transplantation. – 2009. – Vol. 15. – p. 1278–1287.; A prospective, randomized, multicentre trial of systemic adjuvant chemotherapy versus no additional treatment in liver transplantation for hepatocellular carcinoma / G. Söderdahl [et al.] // Transpl. Int. – 2006. – Vol. 19 (4). – p. 288–294.; Benefit of downsizing hepatocellular carcinoma in a livertransplant population / J.W. Jang [et al.] // Aliment. Pharmacol. Ther. – 2009. – Vol. 31. – p. 415–423.; Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China / J. Fan [et al.]// J. Cancer Res. Clin. Oncol. – 2009. – Vol. 135 (10). – p. 1403–1412.; Indicators of prognosis after liver transplantation in Chinese hepatocellular carcinoma patients / J. Li [et al.] // World J. Gastroenterol. – 2009. – Vol. 15 (33). – p. 4170–4176.; Predictors of long-term survival after liver transplantation for hepatocellular carcinoma / C. Zavaglia [et al.] // Am. J. Gastroenterol. – 2005. – Vol. 100 (12). – p. 2708–2716.; Morphological features of advanced hepatocellular carcinoma as a predictor of downstaging and liver transplantation: an intention-to-treat analysis / O. Barakat [et al.] // Liver Transpl. – 2010. – Vol. 16 (3). – p. 289–299.; Tumour size and differentiation in predicting recurrence of hepatocellular carcinoma after liver transplantation: external validation of a new prognostic score / L. Marelli [et al.] // Ann. Surg. Oncol. – 2008. – Vol. 15 (12). – p. 3503– 3511.; Mazzaferro, V. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis / V. Mazzaferro, J. M. Llovet, R. Micelincet // Oncol. – 2009. – Vol. 10 (1). – p. 35–43.; Llovet, J.M. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma / J.M. Llovet, J. Fuster, J. Bruix // Liver. Transpl. – 2004. – Vol. 10. – p. 115–120.; Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time / T. Decaens [et al.] // Liver Transpl. – 2006. – Vol. 12 (12). – p. 1761–1769.; Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database / C. Toso [et al.] // Hepatology. – 2009. – Vol. 49 (3). – p. 832–838.; https://www.jtransplantologiya.ru/jour/article/view/354

الاتاحة: https://www.jtransplantologiya.ru/jour/article/view/354
https://doi.org/10.23873/2074-0506-2012-0-3-15-21

المؤلفون: M. Khubutia Sh., М. Хубутия Ш.

المصدر: Transplantologiya. The Russian Journal of Transplantation; № 2-3 (2011); 4 ; Трансплантология; № 2-3 (2011); 4 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2011-0-2-3

وصف الملف: application/pdf

Relation: https://www.jtransplantologiya.ru/jour/article/view/327/388; https://www.jtransplantologiya.ru/jour/article/view/327

الاتاحة: https://www.jtransplantologiya.ru/jour/article/view/327
https://doi.org/10.23873/2074-0506-2011-0-2-3-4

المؤلفون: V. Khvatov B., N. Borovkova V., E. Kolokolchikova G., O. Konyushko I., N. Koltovoy A., I. Ponomarev N., M. Minina G., A. Pertsev S., M. Khubutia Sh., В. Хватов Б., Н. Боровкова В., Е. Колокольчикова Г., О. Конюшко И., Н. Колтовой А., И. Пономарев Н., М. Минина Г., А. Перцев С., М. Хубутия Ш.

المصدر: Transplantologiya. The Russian Journal of Transplantation; № 2 (2009); 40-43 ; Трансплантология; № 2 (2009); 40-43 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2009-0-2

مصطلحات موضوعية: donor tissues, hematopoietic stem cells, bone marrow, morphological study, immunological study, доноры тканей, гемопоэтические стволовые клетки, костный мозг, морфологическое исследование, иммунологическое исследование

وصف الملف: application/pdf

Relation: https://www.jtransplantologiya.ru/jour/article/view/261/323; Жибурт Е.Б. Стволовые клетки в службе крови. Трансфузиология 2003;2(4):63—75.; Трансфузиологическая гемокоррекция: учебное пособие для врачей. Под ред. А.А. Рагимова. М.: Практическая медицина, 2008.; Хватов В.Б. Клиническая трансфузиология при неотложных состояниях (современные концепции и перспективы). НИИ СП им. Н.В. Склифосовского. М., 2003.; Берсенев А.В. Клеточная трансплантология — история, современное состояние и перспективы. Клеточн трансплантол и тканев инженерия 2005;1:49—56.; Деев Р.В., Берсенев А.В. Роль стволовых стромальных (мезенхимальных) стволовых клеток в формировании гетеротопических оссификатов. Клеточная трансплантол и тканев инженерия 2005;1:46—8.; Рабинович С.С., Селедцов В.И., Астраков С.В. и др. Клеточная терапия в системе реанимации больных с тяжелой черепно-мозговой травмой. Вестн интенс тер 2004;4:24—7.; Хватов В.Б., Ваза А.Ю., Жиркова Е.А., Бочарова В.С. Заместительная клеточная терапия. Трансплантология 2009;(1): 31—3.; Шумаков В.И., Онищенко Н.А., Крашенинников М.Е. и др. Костный мозг как источник получения мезенхимальных клеток для восстановительной терапии поврежденных органов. Вестн трансплантол и искусств органов 2002;4:3—6.; O`Reilly R.J. Allogenic bone marrow transplantation: current status and future directions. Blood 1983;62:941—64.; Blazar B.R., Lasky L.C., Perentesis J.P. et al. Successful donor cell engraftment in a recipient of bone marrow from a cadaveric donor. Blood 1986;67(6):1655—60.; Kushida T., Inaba M., Ikebukuro K. et al. A New Method for Bone Marrow Cell Harvesting. Stem Cells 2000;18(6): 453—6.; Kushida T., Inaba M., Ikebukuro K. et al. Comparison of bone marrow cells harvested from various bones of cynomolgus monkeys at various ages by perfusion or aspiration methods: a preclinical study for human BMT. Stem Cells 2002;20(2):155—62.; https://www.jtransplantologiya.ru/jour/article/view/261

الاتاحة: https://www.jtransplantologiya.ru/jour/article/view/261
https://doi.org/10.23873/2074-0506-2009-0-2-40-43

المؤلفون: M. Khubutia Sh., O. Rzhevskaya N., K. Lazareva E., М. Хубутия Ш., О. Ржевская Н., К. Лазарева Е.

المصدر: Transplantologiya. The Russian Journal of Transplantation; № 2 (2009); 9-14 ; Трансплантология; № 2 (2009); 9-14 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2009-0-2

مصطلحات موضوعية: posttransplantation diabetes mellitus, glucose intolerance, tacrolimus, cadaveric renal allotransplantation, pancreatic allotransplantation, glycosylated hemoglobin, oral sugar-lowering drugs, посттрансплантационный сахарный диабет, нарушение толерантности к глюкозе, такролимус, аллотрансплантация трупной почки, аллотрансплантация поджелудочной железы, гликолизированный гемоглобин, пероральные сахароснижающие препараты

وصف الملف: application/pdf

Relation: https://www.jtransplantologiya.ru/jour/article/view/250/312; Hathaway D.K., Tolley E.A., Blakely M.L. et al. Development of an index to predict post-transplant diabetes mellitus. Clin Transplant 1994;7:330—8.; Friedman E.A., Shyh T., Beyer M.M. et al. Posttransplant diabetes in kidney transplant recipients. Am J Nephrol 1985;5: 196—202.; Vincenti F., Friman S., Scheuermann E. et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transp 2007;7:1506—14.; Howard A. Management of new-onset diabetes mellitus in the kidney transplant recipient. Medscape Transplant 2004; 14 Jul.; Thomas M.C, Moran J., Mathew T.H. et al. Early peri-operative hyperglycaemia and renal allograft rejection in patients without diabetes. BMC Nephrology 2000;1:1.; Pourmand G., Ebrahimi M.R., Mehrsai A.R., Taheri M. Patient blood glucose levels before and after kidney transplantation. Transplant Proc 2000;32(3):566—8.; Min C., Kang E., Yu S.H. et al. Advanced glycation end products induce apoptosis and pro-coagulant activity in cultured human umbilical vein endothelial cells. Diabetes Res Clin Pract 1999;46(3): 197—202.; Pavlovic D., Van de Winkel M., Van der Auwera B. et al. Effect of interferongamma and glucose on major histo-compatibility complex class I and class II expression by pancreatic beta- and non-beta-cells. J Clin Endocrinol Metab 1997;82(7):2329—36.; Foster K.J., Alberti K.G., Binder C. et al. Lipid metabolites and nitrogen balance after abdominal surgery in man. Br J Surg 1979;66(4):242—5.; Spencer C.M., Goa K.L., Gillis J.C. Tacrolimus: an update of its pharmacology and clinical efficacy in the management of organ transplantation. Drugs 1997;54: 925—75.; Jindal R.M., Sidner R.A., Milgrom M.L. Post-transplant diabetes mellitus. The role of immunosuppression. Drug Saf 1997;16: 242—57.; Pirsch J.D., Miller J., Deierhoi M.H. et al. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation 1997;63:977—83.; Cavaille-Coll M.W., Elashoff M.R. Commentary on a comparison of tacrolimus and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation 1998;65:142—3.; Marchetti P., Navalesi R. The metabolic effects of cyclosporine and tacrolimus. J Endocrinol Invest 2000;23:482—90.; Heisel O., Heisel R., Balshaw R., Keown P. New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis. Am J Transplant 2004;4;583—95.; Jain A., Khanna A., Molmenti E.P. et al. Immunosuppressive therapy. Surg Clin North Am 1999;79:59—76.; Johnson C., Ahsan N., Gonwa T. et al. Randomized trial of tacrolimus in combination with azathioprine or mycophenolate mofetil after cadaveric kidney transplantation. Transplantation 2000;63;834—41.; Lazzaro C., McKechnie T., McKenna M. Tacrolimus versus cyclosporin in renal transplantation in Italy: cost-minimisation and cost-effectiveness analyses. J Nephrol 2002;15:580—8.; Vincenti F., Jensik S.C., Filo R.S. et al. A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years. Transplantation 2002;73:775—82.; Weir M.R., Fink J.C. Risk for post-transplant diabetes mellitus with current immunosuppressive medications. Am J Kidney Dis 1999;34:1—13.; Hirano Y., Fujihira S., Ohara K. et al. Morphological and functional changes of islets of Langherans in FK506-treated rats. Transplantation 1992;53:889—94.; Martin F., Bedoya F.J. Mechanisms of action of cyclosporine A on islet alfa-and beta cells. Effects on cAMP and calcium dependent pathways. Life Sci 1991;49:1915—21.; Redmond J.B., Olson L.K., Armstrong M.B. et al. Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells. J Clin Invest 1996;98: 2786—93.; Ishizuka J., Guiuzza K.K., Wassmuth Z. et al. Effects of FK506 and cyclosporine on dynamic insulin secretion from isolated dog pancreatic islet. Transplantation 1993;56:1486—90.; Noguchi N., Takasawa S., Nata K. et al. Cyclic ADP-ribose binds to FK506 binding protein 12.6 to release calcium++ from islet microsome. J Biol Chem 1997;272:3133—6.; Lanerolle R.D., de Abrew K., Fernando D.J., Sheriff M.H. Posttransplant diabetes in Sri Lanka. Transplant Proc 1996;28:1945—7.; Berwerck S., Kahl A., Bechstein W. et al. Clinical use of the euglicemic hyperinsulinemic clamp for diagnosis of tacrolimusinduced insulin resistance after combined pancreas-kidney transplantation. Transplant Proc 1998;30:1944—5.; Basadonna G., Montorsi F., Dakizaki K., Merrell R.C. Cyclosporine A and islet function. Am J Surg 1988;156:191—3.; Bani Sacchi T., Bani D., Filipponi F. et al. Immunocytochemical and ultra structural changes of islet cells in rats treated longterm with cyclosporine at immunotherapeutic doses. Transplantation 1990;49:982—7.; Van Hoff J.P., Christiaans M.H., Ven Duijnhoven E.M. et al. Glucose metabolic disorder after transplantation. Am J Transplant 2007;7:1435—6.; Ciancio G., Burke G., Gaynor J. A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year. Transplantation 2004;77:252—8.; Maes B.D., Kuypers D., Messian T. et al. Post-transplan-tation diabetes mellitus in FK506-treated renal transplant recipients: analysis of incidence and risk factors. Transplantation 2001;72:1655—61.; Pagano G., Cavalco-Perin P., Cassader M. et al. An in vivo and in vitro study of the mechanism of prednisoneinduced insulin resistance in healthy subjects. J Clin Invest 1983;72:1814—20.; Shapiro R., Jordan M.L., Scantlebury V.P. et al. A prospective, randomized trial of FK506/prednisone vs FK506/azathioprine/prednisone in renal transplant patients. Transplant Proc 1995;27:814—7.; Christiansen E., Andersen H., Rasmusse K. et al. Pancreatic b-cell function and glucose metabolism in human segmental pancreas and kidney transplantation. Am Physiol Soc 1993;264(3):441—9.; Andrews R.C., Wolker B.R. Glucocorticoids and insulin resistance: old hormones, new targets. Clin Sci 1999;96:513—23.; Henriksen J.E., Alford F., Ward G.M., Beck-Nielsen H. Risk and mechanism for dexamethazone-induced deterioration of glucose tolerance in non-diabetic first degree relatives of NIDDM patients. Diabetologia 1997;40:1439—48.; Hjelmesaeth J., Hartmann A., Kosstad J. et al. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation 1997;64:979—83.; Jawad F., Rizvi S.A. Post-transplant diabetes mellitus in live-re-lated renal transplantation. Transplant Proc 2000;32:1888.; Boots J.M., Van Duijnhoven E.M., Christiaans M.H. et al. Glucose metabolism in renal transplant recipients on tacrolimus: the effect of steroid withdrawal and tacrolimus trough level reduction. J Am Soc Nephrol 2002;13:221—7.; Vanrenterghem Y. Strategies to reduce or replace steroid dosing. Transplant Proc 1999;31 (Suppl 8A):7—10.; Christiansen E., Tibell A., Volund A.A. et al. Metabolism of oral glucose in pancreas transplant recipients with normal and impaired glucose tolerance. J Clin Endocrinol Metab 1997;82:2299—307.; Gruessner R.W. Tacrolimus in pancreas transplantation: a multi-center analysis. Tacrolimus Pancreas Study Group. Clin Transplant 1997;11:299—312.; Gruessner R.W., Burke G.W., Stratta R. et al. A multi-center analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation. Transplantation 1996;61:261—73.; Sumrani N.B., Delaney V., Ding Z. et al. Diabetes mellitus after renal transplantation in the cyclosporine era: an analysis of risk factors. Transplantation 1991;51:343—7.; Rao M., Jacob C.K., Shastry J.C. Post-renal transplant diabetes mellitus: a retrospective study. Nephrol Dial Transplant 1992;7:1039—42.; Keen H., Jarret R.J., Mc Cartney P. The ten-year follow-up of the Bedford survey (1962—1972): glucose tolerance and diabetes. Diabetologia 1982;22:73—8.; Vesco L., Busson M., Bedrossian J. et al. Diabetes mellitus after renal transplantation. Transplantation 1996;61:1475—8.; Kasiske B.L., Sneyder J.J., Gilbertson D., Matas A.J. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2002;2(Suppl 3):225.; Knoll G.A., Bell R.C. Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials. Br Med J 1999;318:1104—7.; Parikh C., Klem P., Wong C., Chan L. Obesity as an independent predictor of posttransplant diabetes mellitus (PTDM). Am J Transplant 2002;2(Suppl 3):420.; De Mattos A.M., Prather J., Al-Uzri A. et al. Autosomal dominant polycystic kidney disease (ADPKD) as risk factor for the development of posttransplant diabetes mellitus (PTDM). Am J Transplant 2002;2:359.; Cosio F.G., Pesavento T.E., Kim S. et al. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int 2002;62:1440—6.; Revanur V.K., Jardine A.G., Kingsmore D.B. et al. Influence of diabetes mellitus on patients and graft survival in recipients of kidney transplantation. Clin Transplant 2001;15:89—94.; Thomas M.C., Mathew P.H., Russ G.R. et al. Early perioperative glycemic control and allograft rejection in patients with diabetes mellitus: a pilot study. Transplantation 2001;72:1321—4.; Klahr S., Levey A.S., Beck G.J. et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of diet in renal disease study group. N Engl J Med 1994;330:877—84.; Noble N.A., Border W.A. Angiotensin II in renal fibrosis. Should TGF-beta rather than blood pressure be the therapeutic target? Semin Nephrol 1997;17:455—66.; Miles A.M., Sumrani N., Horowitz R. et al. Diabetes mellitus after renal transplantation. Transplantation 1998;65:380—4.; Schneider D.J., Nordt T.K., Sobel B.E. Attenuated fibrinolysis and accelerated atherogenesis in type II diabetic patients. Diabetes 1993;42:1—7.; Maser R.E., Wolfson S.K. Jr., Ellis D. et al. Cardiovascular disease and arterial calcification in insulin-dependent diabetes mellitus: interrelations and risk factor profiles. Arterioscler Thromb 1991;11:958—65 [Abstract].; Laakso M., Pyorala K., Scarlund H., Voutilainen E. Lipid and lipoprotein abnormalities associated with coronary heart disease in patients with insulin-dependent diabetes mellitus. Arteriosclerosis 1986;6:679— 84 [Abstract].; Raine A.E.G. Cardiovascular complications after renal transplantation. In: P.J. Morris (ed.). Kidney transplantation: principles and practice. Philadelphia: PA, Saunders; 1988. p. 575—601.; Hjelmeseth J., Hartmann A., Midvedt K. et al. Metabolic cardiovascular syndrome after renal Transplantation. Nephrol Dial Transplant 2001;16:1047—52.; Von Kiparsky A., Frei D., Uhlschmid G. et al. Post-transplant diabetes mellitus in renal allograft recipients: a matched pair control study. Nephrol Dial Transplant 1990;5:220—5.; Chiu M.Y., Sprague S.M., Bruce D.S. et al. Analysis of fracture prevalence in kidneypancreas allograft recipients. J Am Soc Nephrol 1998;9:677—83.; Marchetti P. Strategies for risk reduction and management of post-transplant diabetes mellitus. Transplant Proc 2001;33(Suppl 5A):27—31.; https://www.jtransplantologiya.ru/jour/article/view/250

الاتاحة: https://www.jtransplantologiya.ru/jour/article/view/250
https://doi.org/10.23873/2074-0506-2009-0-2-9-14

المؤلفون: M. Khubutia Sh., S. Zhuravel V., N. Kuznetsova K., M. Novruzbekov S., A. Chugunov O., I. Alexandrova V., М. Хубутия Ш., С. Журавель В., Н. Кузнецова К., М. Новрузбеков С., А. Чугунов О., И. Александрова В.

المصدر: Transplantologiya. The Russian Journal of Transplantation; № 4 (2012); 60-62 ; Трансплантология; № 4 (2012); 60-62 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2012-0-4

مصطلحات موضوعية: bacterial infection, liver transplantation, tigecycline, бактериальная инфекция, трансплантация печени, тигециклин

وصف الملف: application/pdf

Relation: https://www.jtransplantologiya.ru/jour/article/view/368/429; Терапия сепсиса, вызванного метициллин-резистентным штаммом S. aureus (MRSA), у пациентки после ортотопической трансплантации печени (клиническое наблюдение) / А.О. Чугунов [и др.] // Трансплантология. – 2010. – № 3–4. – С. 46–49.; The Efficacy and Safety of Tigecycline for the Treatment of Complicated IntraAbdominal Infections: Analysis of Pooled Clinical Trial Data / T. Babinchak [et al.] // Clinical Infectious Diseases. – 2005. Vol. 41. – S. 354–367.; Characterization of baseline methicillin– resistant Staphylococcus aureus isolates recovered from phase IV clinical trial for linezolid / R.E. Mendes [et al.] // J. Clinical microbiology. – 2010. – Vol. 48, № 2. – P. 568–574.; Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Disease Society of America / J.S. Solomkin [et al.] // Clinical Infectious Disease. – 2010. – Vol. 50. – P. 133–164.; https://www.jtransplantologiya.ru/jour/article/view/368

الاتاحة: https://www.jtransplantologiya.ru/jour/article/view/368
https://doi.org/10.23873/2074-0506-2012-0-4-60-62

المؤلفون: M. Khubutia Sh., O. Andreitseva I., S. Zhuravel V., V. Gulyaev A., A. Saliyenko A., A. Chzhao V., М. Хубутия Ш., О. Андрейцева И., С. Журавель В., В. Гуляев А., А. Салиенко А., А. Чжао В.

المصدر: Transplantologiya. The Russian Journal of Transplantation; № 1 (2009); 13-19 ; Трансплантология; № 1 (2009); 13-19 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2009-0-1

مصطلحات موضوعية: a waiting list, liver transplantation, examinations of recipients, indications for transplantation, «лист ожидания», трансплантация печени, обследование реципиентов, показания к трансплантации

وصف الملف: application/pdf

Relation: https://www.jtransplantologiya.ru/jour/article/view/234/296; National Organ Transplant Act of 1984 (NOTA). 42 USC §274.; Rosen H.R., Shackleton C.R., Martin P. Indications for and timing of liver transplantation. Med Clin North Am 1996;80:1069—102.; Martin P. Hepatocellular carcinoma: risk factors and natural history. Liver Transplantаnt Surgery 1998;4(suppl)1998;87—91.; Barbara L., Benzi G., Gaiani S. et al. Natural history of small untreated hepatocellular carcinoma in cirrhosis: А multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology 1992;16:132—7.; Sheu J.C., Sung J.L., Chen D.S. et al. Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology 1985;89:259—66.; Carithers R.L.Jr. Liver transplantation. Liver Transplаnt Surgery 1999;6:122—35.; Lucey M.R., Brown K.A., Everson G.T. et al. Minimal criteria for placement of adults on the liver transplant waiting list: A report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transplаnt Surgery 1997;3:628—37.; Krowka M.J., Porayko M.K., Plevak D.J. et al. Hepatopulmonary syndrome with progressive hypoxemia as an indication for liver transplantation: Case reports and literature review. Mayo Clinic Proceedings 1997;72:44—53.; Sherman M., Peltekian K.M., Lee C. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: Incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology 1995;22:432—38.; Miller W.J., Federle M.P., Campbell W.L. Diagnosis and staging of hepatocellular carcinoma: comparison of CT and sonography in 36 liver transplantation patients. Am J Roentgenol 1991;157:303—6.; Oka H., Tamori A., Kuroki T. et al. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology 1994;19:61—6.; Sherman M., Peltekian K.M., Lee C. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: Incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology 1995;22:432—8.; Isobe H., Imari Y., Sakai H. et al. Subcutaneous seeding of hepatocellular carcinoma following fine-needle aspiration biopsy. J Clin Gastroenterol 1993;17:350—2.; Runyon B.A., Antillon M.R., Akriviadis E.A. et al. Bedside inoculation of blood culture bottles with ascitic fluid is superior to delayed inoculation in the detection of spontaneous bacterial peritonitis. J Clin Microbiol 1990;28:2811—2.; Anonymous. Organ Procurement and Transplantation Network—HRSA. Final rule with comment period. Fed Register 1998;63:16296—338.; Malinchoc M., Kamath Р.Q., Gordon F.D. et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosys-temic shunts. Hepatology 2000;31:864.; Kamath P.S., Wiesner R.H., Malmchoc M. et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464.; Brown R.S., Kumar K.S., Russo M.W. et al. Model for end-stage liver disease and GhildTurcotte-Pugh score as predictors of pretransplant disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients. Liver Transplant 2002;8:278.; Desaj N.M., Mange K.C., Crawford M.D. et al. Predicting outcome after liver transplantation of newly derived transplantation: utility of the MODEL FOR END-STAGE LIVER DISEASE and a discrimination function. Transplantation 2004;77:99—106.; Showstack J., Katz P.P., Lake J.R. et al. Resource utilization in liver transplantation: offects of patient characteristics and clinical practice. NIDDK Liver Transplantation Database Group. JAMA 1999;281:1381.; Talwalkar J.A., Seaberg E., Kim W.R. et al. Predicting clinical and economic outcomes after liver transplantation using the Mayo primary sclerosing cholangitis model and ChildPugh score. Liver Transplant 2000:6:753—8.; Schnitzler M.A., Woodward K.S., Brennan D.C. et al. The economic impact of preservation time in cadaveric liver transplantation. Am J Transplant 2001;1:360.; Reilly J., Mehta R., Teperman L. et al. Nutritional support after liver transplant: A randomised prospective study. JPEN 1990;14:386—91.; Keeffe E.B. Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases? Am J Gastroenterol 1995;90:201—5.; Vento S., Garofano T., Renzini C. et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. New Engl J Med 1998;338:286—90.; Lucey M.R., Brown K.A., Everson G.T. et al. Minimal criteria for placement of adults on the liver transplant waiting list: A report of a national conference organized by the American Association for the Study of Liver Diseases. Liver Transplаnt Surgery 1997;3:628—37.; Fattovich G., Giustina G., Degos F. et al. Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients. Gastroenterology 1997;112:463—72.; Serfaty L., Aumaitre H., Chazouilleres O. et al. Determinants of outcome of compensated hepatitis C virus-related cirrhosis. Hepatology 1998;27:1435—40.; Kruger M., Tillmann H., Trautwein C. et al. Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: A pilot study. Liver Transplаnt Surgery 1996;2:253.; Perrillo R., Rakela J., Martin P. et al. Lamivudine for suppression and/or prevention of hepatitis B when given pre/post transplantation. Hepatology 1997;26:260A.; Terrault N., Zhou S., Combs C. et al. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin. Hepatology 1996;24:1327.; O'Grady J., Smith H., Davies S. et al. Hepatitis B virus reinfection after orthotopic liver transplantation. Hepatology 1992;14:104.; Ottobrelli A., Marzano A., Smedile A. et al. Patterns of hepatitis delta virus reinfection and disease in liver transplantation. Gastroenterology 1991;101:1649—53.; Rizzetto M., Ponzetto A., Bonino F. et al. Superimposed hepatitis delta and the effect on viral replication in chronic hepatitis B. Hepatology 1991;3(suppl): 34—41.; Samuel D., Muller R., Alexander G. et al. Liver transplantation in European patients with the hepatitis B surface antigen. New Engl J Med 1993;329:1842.; Feray C., Gigou M., Samuel D. et al. Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation. Ann Inter Med 1998;128:810.; Gane E.J., Portmann B.C., Naoumov N.V. et al. Long-term outcome of hepatitis C infection after liver transplantation. New Engl J Med 1996;334:815—20.; Fukumoto T., Berg T., Ku Y. et al. Viral dynamics of hepatitis C early after orthotopic liver transplantation: Evidence for rapid turnover of serum virions. Hepatology 1996;24:1351—4.; Berenguer M., Ferrell L., Watson J. et al. Fibrosis progression in recurrent hepatitis C virus (HCV) disease: Differences between the U.S. and Europe [abstract]. Hepatology1998;28:220A.; Charlton M., Seaberg E., Wiesner R. et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998;28:823—30.; Feray C., Samuel D., Gigou M. et al. An open trial of interferon alfa recombinant for C after liver transplantation hepatitis: Antiviral effects and risk of rejection. Hepatology 1999;22:1084—9.; Mazzaferro V. et al. Liver transplantation for treatment of small hepatocellular. Carcinomas in patients with cirrhosis. New Engl J Med 1996;334:693—9.; Llovet J., Bruix J., Fuster J. et al. Liver transplantation for small hepatocellular carcinoma: The tumor-node-metastasis classification does not have prognostic power. Hepatology 1998;27:1572.; Mazzaferro V., Regalia E., Montalto F. et al. Risk of HBV reinfection after liver transplantation in HBsAg-positive cirrhosis. Primary hepatocellular carcinoma is not a predictor for HBV recurrence. Liver 1996;16:117—22.; Carithers R.L. Jr. Liver transplantation. Liver Transplаnt Surgery 1999;6:122—35.; Lucey M.R., Brown K.A., Everson G.T. et al. Minimal criteria for placement of adults on the liver transplant waiting list: A report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transplant Surgery 1997;3:628—37.; https://www.jtransplantologiya.ru/jour/article/view/234

الاتاحة: https://www.jtransplantologiya.ru/jour/article/view/234
https://doi.org/10.23873/2074-0506-2009-0-1-13-19

المؤلفون: M. Khubutia Sh., V. Nikulina P., M. Godkov A., V. Syutkin E., O. Andreitseva I., A. Chzhao V., М. Хубутия Ш., В. Никулина П., М. Годков А., В. Сюткин Е., О. Андрейцева И., А. Чжао В.

المصدر: Transplantologiya. The Russian Journal of Transplantation; № 2 (2009); 25-31 ; Трансплантология; № 2 (2009); 25-31 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2009-0-2

مصطلحات موضوعية: immunosuppression, cyclosporine, tacrolimus, immunological results, иммуносупрессия, циклоспорин, такролимус, иммунологические результаты

وصف الملف: application/pdf

Relation: https://www.jtransplantologiya.ru/jour/article/view/260/322; Starzl T.E., Murase N., Abu-Elmagd K. et al. Tolerogenic immunosuppression for organ transplantation. Lancet 2003;361:1502—10.; Starzl T.E., Demetris A.J. Liver Transplantation. Chicago, IL; 1990.; Reding R. Steroid withdrawal in liver transplantation: benefits, risks and unanswered questions. Transplantation 2000;70:405—10.; Kasiske B.L., Chakkera H.A., Louis T.A., Ma J.Z. A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol. 2000;11:1910—7.; Lerut J. Avoiding steroids in solid organ transplantation. Transpl Int 2003;16:213—24.; Lerut J., Mathys J., Verbaandert C. et.al. Tacrolimus monotherapy in liver transplantation one-year results of a prospective, randomized, double-blind, placebo. Ann Surg 2008;248:956—67.; Sherlock S., Dooley J. Diseases of the liver and biliary system. 11. Oxford: Blackwell Science Ltd; 2002.; Vilatoba M., Contreras J.L., Eckhoff D.E. New immunosuppressive strategies in liver transplantation: balancing efficacy and toxicity. Current Opin Organ Transplant 2003;8:139—45.; Wiesner R.H., Demetris A.J., Belle S.H. et al. Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome. Hepatology 1998;28:638—45.; Neuberger J., Adams D.H. What is the significance of acute liver allograft rejection? J Hepatol 1998;29:143—50.; Lowes J.R., Hubscher S.G., Neuberger J.M. Chronic rejection of the liver allograft. Gastroenterol Clin North Am 1993;22:401—20.; Ojo A.O., Held P.J., Port F.K. et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003;349: 931—40.; Kahan B.D. The limitations of calcineurin and mTOR inhibitors: new directions for immunosuppressive strategies. Transplant Proc 2002;34:130—3.; The U.S. Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994;331:1110—5.; Neuhaus P., Langrehr J.M., Williams R. et al. Tacrolimus-based immunosuppression after liver transplantation: a randomised study comparing dual versus triple low-dose oral regimens. Transplant Int 1997;10:253—61.; Ekberg H. Tailoring minimal immunosuppression long term. Transplant Proc 2003;35:755—7.; Schreuder T.C., Hübscher S.G., Neuberger J. Autoimmune liver diseases and recurrence after orthotopic liver transplantation: what have we learned so far? Transpl Int 2009;22(2):144—52.; Duclos-Valle’e J.C. Recurrence of autoimmune hepatitis, primary biliary cirrhosis and primary sclerosing cholangitis after liver transplantation. Acta Gastroenterol Belg 2005;68 (3):331—6.; Washburn K., Speeg K.V., Esterl R. et al. Steroid elimination 24 hours after liver transplantation using daclizumab, tacrolimus, and mycophenolate mofetil. Transplantation 2001;72(10):1675—9.; Nancy Agmon-Levin MD1, Bat-sheva Porat Katz MD2 and Yehuda Shoenfeld MD FRCP1. Infection and primary biliary cirrhosis. IMAJ 2008;10:112—5.; https://www.jtransplantologiya.ru/jour/article/view/260

الاتاحة: https://www.jtransplantologiya.ru/jour/article/view/260
https://doi.org/10.23873/2074-0506-2009-0-2-25-31

المؤلفون: M. Khubutia Sh., N. Borovkova V., R. Storozhev V., N. Doronina V., M. Storozheva V., A. Pertsev S., A. Pinchuk V., М. Хубутия Ш., Н. Боровкова В., Р. Сторожев В., Н. Доронина В., М. Сторожева В., А. Перцев С., А. Пинчук В.

المصدر: Transplantologiya. The Russian Journal of Transplantation; № 3-4 (2010); 32-36 ; Трансплантология; № 3-4 (2010); 32-36 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2010-0-3-4

مصطلحات موضوعية: HLA antibodies, kidney transplantation, rejection crisis, nitrogen-excretory function, HLA-антитела, трансплантация почки, криз отторжения, азотвыделительная функция

وصف الملف: application/pdf

Relation: https://www.jtransplantologiya.ru/jour/article/view/292/355; Kaneku Н.К., Terasaki P.I. Thirty year trend in kidney transplants: UCLA and UNOS renal transplants registry. Clin transpl 2006;1–28.; Lachmann N., Terasaki P.I., Schoenemann C. Donor-specific HLA antibodies in cronic renal allograft rejection: a prospective trial with a fouryear follow-up. In: Terasaki P., ed. Clin transpl 2006;171–200.; Morales-Buenrostro L.E., Rodríguez-Romo R., de Leo C. et al. HLA and MICA antibodies: further evidence of their impact on graft loss two years after their detection. Clin transpl 2006;207–18.; Rebellato L.M., Ozawa M., Verbanac K.M. et al. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor specific and non-donor-specific antibody development. Clin transpl 2006: 241–54.; Mizutani K., Shibata L., Ozawa M. et al. Detection of HLA and MICA antibodies before kidney graft failure. Clin transpl 2006:255–64.; Tanabe K., Ishida H., Omoto K. et al. Antibody-mediated rejection: a single center experience at Tokyo Women’s Medical University. Clin transpl 2006: 363–70.; Lefaucheur C., Loupy A., Hill G.S. et al. Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. J Am Soc Nephrol 2010;21:1398–406.; Terasaki P.I. Predicting kidney graft failure by HLA antibodies: a prospective trial. Am J Transpl 2004;4:438–43.; Akalin E., Dinavahi R., Friedlander R. et al. Addition of plasmapheresis decreases the incidence of acute antibody-mediated rejection in sensitized patients with strong donor-specific antibodies. Clin J Am Soc Nephrol 2008; 3:1160–7.; Langan L.L., D'Orsogna L., Park L.P. et al. HLA antibodies and soluble CD30 are associated with poor renal graft outcome: updated results of a single-center cross-sectional study. Clin transpl 2006:219–26.; https://www.jtransplantologiya.ru/jour/article/view/292

الاتاحة: https://www.jtransplantologiya.ru/jour/article/view/292
https://doi.org/10.23873/2074-0506-2010-0-3-4-32-36

المؤلفون: M. Khubutia Sh., М. Хубутия Ш.

المصدر: Transplantologiya. The Russian Journal of Transplantation; № 4 (2012); 4 ; Трансплантология; № 4 (2012); 4 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2012-0-4

وصف الملف: application/pdf

Relation: https://www.jtransplantologiya.ru/jour/article/view/357/418; https://www.jtransplantologiya.ru/jour/article/view/357

الاتاحة: https://www.jtransplantologiya.ru/jour/article/view/357
https://doi.org/10.23873/2074-0506-2012-0-4-4

المؤلفون: M. Khubutia Sh., N. Karasev A., B. Kurilin L., М. Хубутия Ш., Н. Карасев А., Б. Курилин Л.

المصدر: Transplantologiya. The Russian Journal of Transplantation; № 4 (2011); 9-12 ; Трансплантология; № 4 (2011); 9-12 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2011-0-4

مصطلحات موضوعية: organ donorship, reanimation material well-being, donor potential, insufficiency of donors, service of transplantation coordinators, органное донорство, реанимационная обеспеченность, донорский потенциал, недостаток доноров, служба трансплантационных координаторов

وصف الملف: application/pdf

Relation: https://www.jtransplantologiya.ru/jour/article/view/315/376; Багненко, С.Ф. Основные причины дефицита донорских органов и возможные пути его преодоления/С.Ф. Багненко, И.В. Логинов, О.Н. Резник//3-я науч. конф. «Московская трансплантология»: материалы конф. -Т. 218. -М.: НИИ скорой помощи им. Н.В. Склифосовского, 2011. -С. 4-5.; Багненко, С.Ф. Этапы донорского процесса, определения органного донорства и донорский аудит/С.Ф. Багненко, И.В. Логинов, О.Н. Резник//3-я науч. конф. «Московская трансплантология»: материалы конф. -Т. 218. -М.: НИИ скорой помощи им. Н.В. Склифосовского 2011. -С. 6-7.; Виноградов, В.Л. Координация органного донорства в многопрофильном стационаре/В.Л. Виноградов, И.Ю. Ларионов, В.А. Гуляев//3-я науч. конф. «Московская трансплантология»: материалы конф. -Т. 218. -М.: НИИ скорой помощи им. Н.В. Склифосовского, 2011. -С. 3-4.; Грозовский, К. Координация органного донорства в Израиле/К. Грозовский//3-я науч. конф. «Московская трансплантология»: материалы конф. -Т. 218. -М.: НИИ скорой помощи им. Н.В. Склифосовского, 2011. -С. 7-8.; Анестезиолого-реаниматологическое обеспечение начального этапа программы трансплантации сердца в многопрофильном городском стационаре/И.А. Козлов //3-я науч. конф. «Московская трансплантология»: материалы конф. -Т. 218. -М.: НИИ скорой помощи им. Н.В. Склифосовского, 2011. -С. 10-11.; Мартынюк А.П. Проблемы констатации «смерти мозга» в трансплантации органов в Московской области/А.П. Мартынюк //3-я науч. конф. «Московская трансплантология»: материалы конф. -Т. 218. -М.: НИИ скорой помощи им. Н.В. Склифосовского, 2011. -С. 6.; Минина, М.Г. Критические составляющие донорского процесса/М.Г. Минина//3-я науч. конф. «Московская трансплантология»: материалы конф. -Т. 218. -М.: НИИ скорой помощи им. Н.В. Склифосовского, 2011. -С. 3.; Опыт анестезиологического пособия и интенсивной терапии при ретран сплантации сердца/В.Н. Попцов //3-я науч. конф. «Московская трансплантология»: материалы конф. -Т. 218. -М.: НИИ скорой помощи им. Н.В. Склифосовского, 2011. -С. 11-12.; Анализ реанимационной деятельности многопрофильных больниц департамента здравоохранения г. Москвы, включенных в программу трансплантации органов/М.Ш. Хубутия///3-я науч. конф. «Московская трансплантология»: материалы конф. -Т. 218. -М.: НИИ скорой помощи им. Н.В. Склифосовского, 2011. -С. 58.; Хубутия, М.Ш. Автоматизированная информационная система службы трансплантологии/М.Ш. Хубутия, Н.А. Карасев, В.А. Васильев//3-я науч. конф. «Московская трансплантология»: материалы конф. -Т. 218. -М.: НИИ скорой помощи им. Н.В. Склифосовского, 2011. -С. 59-60.; https://www.jtransplantologiya.ru/jour/article/view/315

الاتاحة: https://www.jtransplantologiya.ru/jour/article/view/315
https://doi.org/10.23873/2074-0506-2011-0-4-9-12

المؤلفون: M. Khubutia Sh., M. Minina G., М. Хубутия Ш., М. Минина Г.

المصدر: Transplantologiya. The Russian Journal of Transplantation; № 2-3 (2011); 22-23 ; Трансплантология; № 2-3 (2011); 22-23 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2011-0-2-3

وصف الملف: application/pdf

Relation: https://www.jtransplantologiya.ru/jour/article/view/330/391; https://www.jtransplantologiya.ru/jour/article/view/330

الاتاحة: https://www.jtransplantologiya.ru/jour/article/view/330
https://doi.org/10.23873/2074-0506-2011-0-2-3-22-23

المؤلفون: M. Khubutia Sh., М. Хубутия Ш.

المصدر: Transplantologiya. The Russian Journal of Transplantation; № 4 (2012); 30-33 ; Трансплантология; № 4 (2012); 30-33 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2012-0-4

وصف الملف: application/pdf

Relation: https://www.jtransplantologiya.ru/jour/article/view/362/423; https://www.jtransplantologiya.ru/jour/article/view/362

الاتاحة: https://www.jtransplantologiya.ru/jour/article/view/362
https://doi.org/10.23873/2074-0506-2012-0-4-30-33

المؤلفون: M. Khubutia Sh., S. Zhuravel V., A. Talyzin M., V. Kiselev V., Ye. Dorofeyeva R., N. Kuznetsova K., A. Chzhao V., М. Хубутия Ш., С. Журавель В., А. Талызин М., В. Киселев В., Е. Дорофеева Р., Н. Кузнецова К., А. Чжао В.

المصدر: Transplantologiya. The Russian Journal of Transplantation; № 2 (2009); 15-18 ; Трансплантология; № 2 (2009); 15-18 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2009-0-2

مصطلحات موضوعية: orthotopic liver transplantation, selenium level, selenase, ортотопическая трансплантация печени, уровень селена, селеназа

وصف الملف: application/pdf

Relation: https://www.jtransplantologiya.ru/jour/article/view/258/320; Angstwurm M.W.A., Engelmann L., Zimmenmann T. et al. Selenium in Intensive Care (SIC) study: Results of a prospective randomized, placebo-controlled, multiplecenter study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med 2007;35(1): 35—40.; Мухачева С.Ю., Руднов В.А., Галян С.Л., Кадочникова Т.Ю. Эффективность селена и α-токоферола в терапии больных с абдоминальным сепсисом. Инфекции в хирургии 2007;5(1):32—6.; Глушко А.В., Яковлева И.И., Гельфанд Б.Р. Опыт использования препарата Селеназа в комплексе интенсивной терапии больных с деструктивным панкреатитом. Инфекции в хирургии 2008;6(1):54—6.; Berger M.M., Eggimann P., Heyaland D.K. et al. Reduction of nosocomial pneumonia after major burns by trace element supplementation: aggregation of two randomized trials. Crit Care 2006;10:153.; Sakr Y. Time course and relationship between plasma selenium concentrations, systemic inflammatory response, sepsis, and multiorgan failure. Br J Anaesthesia 2007;98(6):775—84.; Jaeschke H. Mechanisms of reperfusion injury after warm ischemia of the liver. J Hepatobiliary Pancreat Surg 1998;5(4): 402—8.; Carden D., Granger D. Pathophysiology of ischemia-reperfusion injury. J Pathol 2000;190:256—66.; Zapletal C., Heyne S., Breitkreutz R. The influence of selenium substration on microcirculation and glutathione metabolism after warm liver ishemia/reperfusion in a rat model. Microvasc Res 2008;76(2):1040—1.; https://www.jtransplantologiya.ru/jour/article/view/258

الاتاحة: https://www.jtransplantologiya.ru/jour/article/view/258
https://doi.org/10.23873/2074-0506-2009-0-2-15-18

المؤلفون: M. Khubutia Sh., S. Gilyarevsky R., V. Sokolov V., E. Kovaleva V., I. Kuzmina M., E. Boichevskaya I., М. Хубутия Ш., С. Гиляревский Р., В. Соколов В., Е. Ковалева В., И. Кузьмина М., Е. Бойчевская И.

المصدر: Transplantologiya. The Russian Journal of Transplantation; № 3-4 (2010); 50-63 ; Трансплантология; № 3-4 (2010); 50-63 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2010-0-3-4

مصطلحات موضوعية: heart transplantation, heart failure, mechanical extracorporeal circulation device, agents having positive inotropic action, трансплантация сердца, сердечная недостаточность, механическое устройство для вспомогательного кровообращения, препараты с положительным инотропным действием

وصف الملف: application/pdf

Relation: https://www.jtransplantologiya.ru/jour/article/view/295/358; Dickstein K., Cohen-Solal A., Filippatos G. et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933–89.; Jhund P.S., Macintyre K., Simpson C.R. et al. Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation 2009; 119:515–23.; Shafazand M., Schaufelberger M., Lappas G. et al. Survival trends in men and women with heart failure of ischaemic and non-ischaemic origin: data for the period 1987–2003 from the Swedish Hospital Discharge Registry. Eur Heart J 2009; 30:671–8.; Gridelli B., Remuzzi G. Strategies for making more organs available for transplantation. N Engl J Med 2000;343:404–10.; Costanzo M.R., Augustine S., Bourge R. et al. Selection and treatment of candidates for heart transplantation: a statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation 1995; 92:3593–612.; 1999 Annual Report of the U.S. Scientific Registry of Transplant Recipients and the Organ Procurement and Transplantation Network: Transplant Data 1989–1998. Richmond, VA: HHS/GRSA/OSP/DOT and United Network for Organ Sharing, 1999.; Mancini D., Lietz K. Selection of Cardiac Transplantation Candidates in 2010. Circulation 2010;122:173–83.; Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS). 2007;2(28). http://www.intermacs.org/membership.aspx; Stevenson L.W., Pagani F.D., Young J.B. et al. INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant 2009;28:535–41.; John R., Liao K., Lietz K. et al. Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure. J Thorac Cardiovasc Surg 2007;134:351–8.; Acker M. Mechanical circulatory support for patients with acutefulminant myocarditis. Ann Thorac Surg 2001;71:73–6.; Alba A.C., Rao V., Ivanov J. et al. Usefulness of the INTERMACS scale to predict outcomes after mechanical assist device implantation. J Heart Lung Transplant 2009;28:827–33.; Lietz K., Deng M., Morgan J. et al. Selection of UNOS status 1A candidates for mechanical circulatory support as bridgetotransplantation (BTT): analysis of UNOS/ OPTN 2000–2005. J Heart Lung Transplant 2008;27:244. Abstr.; Lietz K., Long J.W., Kfoury A.G. et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 2007;116:497–505.; Patlolla V., Patten R., DeNofrio D. et al. The effect of ventricular assist devices on posttransplant mortality: an analysis of the United Network of Organ Sharing Thoracic Registry. J Am Coll Cardiol 2009;53:264–71.; Rose E.A., Gelijns A.C., Moskowitz A.J. et al. for the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001;345:1435–43.; Califf R., Adams K., McKenna W. et al. A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: the Flolan International Randomized Survival Trial (FIRST). Am Heart J 1997;134:44–54.; Herschberger R., Nauman D., Walker T. et al. Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure. J Card Fail 2003;9:180–7.; Stevenson L. Clinical use of inotropic therapy for heart failure: looking backwards and forward, part II: chronic inotropic therapy. Circulation 2003;108:492–7.; Zimmermann N., Boknik P., Gams E. et al. Calcium sensitization as new principle of inotropic therapy in end-stage heart failure? Eur J Cardiothorac Surg 1998;14:70–5.; Current U.S. Waiting list for heart transplant candidates: based on OPTN data as of January 1, 2007. 2009;6(1). http://www.optn.org/latestData/rptData.asp; Stevenson L.W., Miller L.W., DesvigneNickens P. et al. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure). Circulation 2004;110:975–81.; Slaughter M., Rogers J., Milano C. et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009;361:2241–51.; Fukamachi K., McCarthy P., Smedira N. et al. Pre-operative risk factors for right ventricular failure after implantable left ventricular device insertion. Ann Thorac Surg 1999;68:2181–4.; Ochiai Y., McCarthy P., Smedira N. et al. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients. Circulation 2002;106:II198–I202.; Kavarana M., Pessin-Minsley M., Urtecho J. et al. Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem. Ann Thorac Surg 2002;73:745–50.; Matthews J.C., Koelling T.M., Pagani F.D. et al. The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol. 2008;51:2163–72.; Fitzpatrick J.R. 3rd, Frederick J.R., Hsu V.M. et al. Risk score derived from preoperative data analysis predicts the need for biventricular mechanical circulatory support. J Heart Lung Transplant 2008;27:1286–92.; Itescu S., John R. Interactions between the recipient immune system and LVAD surface: immunological and clinical implications. Ann Thorac Surg 2003;75:58–65.; Taylor D., Stehlik J., Edwards L. et al. Registry of the International Society for Heart and Lung Transplantation: twenty-sixth official adult heart transplant report: 2009. J Heart Lung Transplant 2009;28:1007–22.; Klovaite J., Gustafsson F., Mortensen S. et al. Severely impaired von Willebrand factor dependent platelet aggregation in patients with a continuous flow left ventricular assist device (Heartmate II). J Am Coll Cardiol 2009;53:2162–7.; Mancini D., Eisen H., Kussmaul W. et al. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991;83:778–86.; Guazzi M., Myers J., Abella J., et al. The added prognostic value of ventilatory efficiency to the Weber classification in patients with heart failure. Int J Cardiol 2008;129:86–92.; Lang C., Karlin P., Haythe J. et al. Peak cardiac power output measured non-invasively, is a powerful predictor of outcome in chronic heart failure. Circ Heart Fail 2009;2:33–8.; Aaronson K., Mancini D. Is percent predicted VO2 a better selection criterion than peak VO2 for cardiac transplantation? J Heart Lung Transplant 1995;14:981–9.; Aaronson K., Schwartz J.S., Chen T. et al. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997;95:2660–7.; Lund L., Aaronson K., Mancini D. Predicting survival in ambulatory patients with severe heart failure on beta blocker therapy. Am J Cardiol 2003;92:1350–4.; Koelling T., Joseph S., Aaronson K. Heart Failure Survival Score continues to predict outcomes in patients receiving beta blockers. J heart Lung Transplant 2004;23:1414–22.; O’Neill J., Young J., Pothier C. et al. Peak oxygen consumption as a predictor of death in patients with heart failure receiving beta blockers. Circulation 2005;111:2313–8.; Lund L., Aaronson K., Mancini D. Validation of Peak VO2 and the Heart Failure Survival Score for serial risk stratification in advanced heart failure. J Am Cardiol 2005;95:734–41.; Levy W.C., Mozaffarian D., Linker D.T. et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 2006;113:1424–33.; Gorodeski E.Z., Chu E.C., Chow C.H. et al. Application of the Seattle Heart Failure Model in Ambulatory Patients Presented to an Advanced Heart Failure Therapeutics Committee. Circ Heart Fail 2010;8(26).; De Meester J.M., Smits J.M., Heinecke J. et al. Effect of receiving a heart transplant: analysis of a national cohort entered on to a waiting list, stratified by heart failure severity: Comparative Outcome and Clinical Profiles in Transplantation (COCPIT) Study Group. BMJ 2000;321:540–5.; Jimenez J., Bennett-Edwards L., Higgins R. et al. Should we transplant UNOS status 2 patients? J Heart Lung Transplant 2005;24:178–83.; Kirklin J.K., Naftel D.C., Caldwell R. et al. Should status 2 patients be removed from the pediatric heart transplant waiting list? A multiinstitutional study. J Heart Lung Transplant 2006;25:271–5.; Deng M.C., Smits J.M., Young J.B. Proposition: the benefit of cardiac transplantation in stable outpatients with heart failure should be tested in a randomized trial. J Heart Lung Transplant 2003;22:113–7.; Mokadam N.A., Ewald G.A., Damiano R.J. et al. Deterioration and mortality among patient with United Network for Organ Sharing status 2 heart disease: caution must be exercised in diverting organs. J Thorac Cardiovasc Surgery 2006;131:925–6.; Mehra M., Kobashigawa J., Starling R. et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation Guidelines for the care of cardiac transplant candidates: 2006 . J Heart Lung Transplant 2006;25:1024–42.; Aurora P., Edwards L., Christie J. et al. Registry of the International Society for Heart and Lung Transplantation: eleventh official pediatric lung and heart/lung transplantation report: 2008 . J Heart Lung Transplant 2008;27:978–83.; Morgan J.A., John R., Mancini D.M. et al. Should heart transplantation be considered as a treatment option for patients aged 70 years and older? J Thorac Cardiovasc Surg 2004;127:1817–9.; Morgan J.A., John R., Weinberg A.D. et al. Long-term results of cardiac transplantation in patients 65 years of age and older: a comparative analysis. Ann Thorac Surg 2003;76:1982–7.; Weiss E.S., Nwakanma L.U., Patel N.D. et al. Outcomes in patients older than 60 years of age undergoing orthotopic heart transplantation: an analysis of the UNOS database. J Heart Lung Transplant 2008;27:184–91.; Tjang Y.S., van der Heijden G.J., Tenderich G. et al. Impact of recipient’s age on heart transplantation outcome. Ann Thorac Surg 2008;85:2051–5.; Marielli D., Kobashigawa J., Hamilton M. et al. Long term outcomes of heart transplantation in older recipients. J Heart Lung Transplant 2008;27:830–4.; Murali S., Kormos R., Uretsky B. et al. Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: the Pittsburgh experience. Am Heart J 1993;126:896–904.; Chen J., Levin H., Michler R. et al. Reevaluating the significance of pulmonary hypertension before cardiac transplantation: determination of optimal thresholds and quantification of the effect of reversibility on peri-operative mortality. J Thorac Cardiovasc Surg 1997;114:627–34.; Lindelow B., Anderson B., Waagstein F. et al. High and low pulmonary vascular resistance in heart transplant candidates. Eur Heart J 1999;20:148–56.; The Registry of the International Society for Heart and Lung Transplantation. 2009;6(1). http://www.ishlt.org/registries/slides; Zimpler D., Zrunek P., Sandner S. et al. Post transplant survival after lowering pulmonary hypertension using left ventricular assist devices. J Cardiothorac Surg 2007;31:698–702.; Etz C., Welp H., Tjan T. et al. Medically refractory pulmonary hypertension: treatment with non pulsatile left ventricular assist devices. Ann Thorac Surg 2007;83:1697–706.; Lang C., Beniaminovitz A., Edwards N. et al. Morbidity and mortality in diabetic patients following cardiac transplantation. J Heart Lung Transplant 2003;22:244–9.; Cimato T., Jessup M. Recipient selection in cardiac transplantation: contraindications and risk factors for mortality. J Heart Lung Transplant 2002;21:1161–73.; Russo M., Chen J., Hong K. et al. Survival after heart transplantation is not diminished among recipients with uncomplicated diabetes mellitus: an analysis of the United Network of Organ Sharing Database. Circulation 2006;114:2280–7.; Almuti K., Haythe J., Tsao L. et al. Does renal function deteriorate more rapidly in diabetic cardiac transplant recipients? Transplantation 2007;83:550–3.; Russo M., Rana A., Chen J. et al. Pretransplantation patient characteristics and survival following combined heart and kidney transplantation. Arch Surg 2009;144:241–6.; Porter K., Babiker A., Bhaskaran K. et al. Determinants of survival following HIV-1 seroconversion after the introduction of HAART. Lancet 2003;362:1267–74.; Sackoff J.E., Hanna D.B., Pfeiffer M.R. et al. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med 2006;145:397–406.; Calabrese L.H., Albrecht M., Young J. et al. Successful cardiac transplantation in an HIV-1-infected patient with advanced disease. N Engl J Med 2003;348:2323–8.; Gupta S., Markham D.W., Mammen P.P. et al. Long-term follow-up of a heart transplant recipient with documented seroconversion to HIV-positive status 1 year after transplant. Am J Transplant 2008;8:893–6.; Uriel N., Jorde U.P., Cotarlan V. et al. Heart transplantation in human immunodeficiency virus-positive patients. J Heart Lung Transplant 2009;28:667–9.; Hosenpud J., DeMarco T., Frazier O.H. et al. Progression of systemic disease and reduced long-term survival in patients with cardiac amyloidosis undergoing heart transplantation: follow-up results of a multicenter survey. Circulation 1991;84(Suppl):III338–43.; Dubrey S., Burke M., Hawkins P. et al. Cardiac transplantation for amyloid heart disease: the United Kingdom experience. J Heart Lung Transplant 2004;23:1142–53.; Maurer M., Raina A., Hesdorffer C. et al. Preliminary experience of cardiac transplantation using extended donor organs for systemic amyloidosis complicated by heart failure. Transplantation 2007;83:539–45.; Hamour I., Lachmann H., Goodman H. et al. Heart transplantation for homozygous familial transthyretin (TTR) V 1221 cardiac amyloidosis. Am J Transplant 2008;8:1056–9.; Sack F., Kristen A., Goldschmidt H. et al. Treatment options for severe cardiac amyloidosis: heart transplantation combined with chemotherapy and stem cell transplantation for patients with AL amyloidosis and heart and liver transplantation for patients with ATTR-amyloidosis. Eur J Cardiothorac Surg 2008;33:257–62.; Surakomol S., Olson L.J., Rastogi A. et al. Combined orthotopic heart and liver transplantation for genetic hemochromatosis. J Heart Lung Transplant 1997;16:573–5.; Hsu R.B., Chang C.I., Lin F.Y. et al. Heart transplantation in patients with liver cirrhosis. Eur J Cardiothorac Surg 2008;34:307–12.; Laks H., Marelli D., Fonarow G. et al. Use of two recipient lists for adults requiring heart transplantation. J Thorac Cardiovasc Surg 2003;125:49–59.; Chen J., Russo M., Hammond K. et al. Alternate waiting list strategies for heart transplantation maximize donor organ utilization. Ann Thorac Surg 2005;80:224–8.; Shivalkar B., Van Loon J., Wieland W. et al. Variable effects of explosive or gradual increase of intracranial pressure on myocardial structure and function. Circulation 1993;87:230–9.; Stoica S.C., Satchihananda D.K., White P.A. et al. Brain death leads to abnormal contractile properties of the human donor right ventricle. J Thorac Cardiovasc Surg 2006;132:116–23.; Novitzky D. Detrimental effects of brain death on the potential organ donor. Transplant Proc 1997;29:3770–2.; Taylor D.O., Edwards L.B., Aurora P. et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-fifth Official Adult Heart Transplant Report–2008. Heart Lung Transplant 2008;27:943–56.; Berman M., Ali A., Ashley E. et al. Is stress cardiomyopathy the underlying cause of ventricular dysfunction associated with brain death? J Heart Lung Transplant 2010; 29:957–65.; Stoica S.C., Satchihananda D.K., White P.A. et al. Noradrenaline use in human donor and relationship with load-independent right ventricular contractility. Transplantation 2004;78:1193–7.; Bittner H.B., Kendall S.W., Chen E.P. et al. The combined effects of brain death and cardiac graft preservation on cardiopulmonary hemodynamics and function before and after subsequent heart transplantation. J Heart Lung Transplant 1996;15:764–77.; Kendall S.W., Bittner H.B., Peterseim D.S. et al. Right ventricular function in the donor heart. Eur J Cardiothorac Surg 1997; 11:609–15.; Bittner H.B., Chen E.P., Biswas S.S. et al. Right ventricular dysfunction after cardiac transplantation: primarily related to the status of donor heart. Ann Thorac Surg 1999;68:1605–11.; Talaj J.A., Kirklin J.A., Brown R.N. et al. Post-heart transplant diastolic dysfunction is a risk factor for mortality. J Am Coll Cardiology 2007;50:1064–9.; Berman M., Ali A., Ashley E. et al. Is stress cardiomyopathy the underlying cause of ventricular dysfunction associated with brain death? J Heart Lung Transplant 2010;29:957–65.; Copeland J.G., Griepp R.B., Bieber C.P. et al. Successful retransplantation of the human heart. J Thorac Cardiovasc Surg 1977; 73:242–7.; Tjang Y.S., Tenderich G., Hornik L. et al. Cardiac retransplantation in adults: an evidence-based systematic review. Thorac Cardiovasc Surg 2008;56:323–7.; Srivastava R., Keck B.M., Bennett L.E. et al. The results of cardiac retransplantation: an analysis of the Joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry. Transplantation 2000;70:606–12.; Topkara V.K., Dang N.C., John R. et al. A decade experience of cardiac retransplantation in adult recipients. J Heart Lung Transplant 2005;24:1745–50.; Magee J.C., Barr M.L., Basadonna G.P. et al. Repeat organ transplantation in the United States, 1996–2005. Am J Transplant 2007;71424–33.; Karwande S.V., Ensley R.D., Renlund D.G. et al. Cardiac retransplantation: a viable option? The Registry of the International Society for Heart and Lung Transplantation. Ann Thorac Surg 1992;54:840–4.; Schnetzler B., Pavie A., Dorent R. et al. Heart retransplantation: a 23-year singlecenter clinical experience. Ann Thorac Surg 1998;65:978–83.; Smith J.A., Ribakove G.H., Hunt S.A. et al. Heart retransplantation: the 25-year experience at a single institution. J Heart Lung Transplant 1995;14:832–9.; Chin C., Naftel D., Pahl E. et al. Cardiac Re-transplantation in pediatrics: a multiinstitutional study. J Heart Lung Transplant 2006;25:1420–4.; John R., Chen J.M., Weinberg A. et al. Long-term survival after cardiac retransplantation: a twenty-year singlecenter experience. J Thorac Cardiovasc Surg 1999;117:543–55.; Tsao L., Uriel N., Leitz K. et al. Higher rate of co-morbidities post cardiac retransplantation contribute to decreased survival. J Heart Lung Transplant 2009;28:1072–4.; Johnson M.R., Aaronson K.D., Canter C.E. et al. Heart retransplantation. Am J Transplant 2007;7:2075–81.; Chen J., Davies R., Mital S. et al. Trends and outcomes in transplantation for complex congenital heart disease: 1984–2004. Ann Thoracic Surg 2004;78:1352–61.; Lamour J., Kanter K., Naftel D. et al. The effect of age, diagnosis, and previous surgery in children and adults undergoing heart transplantation for congenital heart disease. J Am Coll Cardiol 2009;54:160–5.; Patel N.D., Weiss E.S., Allen J.G. et al. Heart transplantation for adults with congenital heart disease: analysis of the United Network for Organ Sharing database. Ann Thorac Surg 2009;8:814–21.; https://www.jtransplantologiya.ru/jour/article/view/295

الاتاحة: https://www.jtransplantologiya.ru/jour/article/view/295
https://doi.org/10.23873/2074-0506-2010-0-3-4-50-63

المؤلفون: M. Khubutia Sh., N. Kudryashova E., O. Sinyakova G., I. Aleksandrova V., E. Pervakova I., O. Andreitseva I., A. Chzhao V., М. Хубутия Ш., Н. Кудряшова Е., О. Синякова Г., И. Александрова В., Э. Первакова И., О. Андрейцева И., А. Чжао В.

المصدر: Transplantologiya. The Russian Journal of Transplantation; № 1 (2010); 5-10 ; Трансплантология; № 1 (2010); 5-10 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2010-0-1

مصطلحات موضوعية: scintigraphy, radionuclides, liver transplantation, сцинтиграфия, радионуклиды, трансплантация печени

وصف الملف: application/pdf

Relation: https://www.jtransplantologiya.ru/jour/article/view/263/326; Афукова О.А., Юдин А.Л. Лучевая диагностика цирроза печени. Мед визуал 2005;5:32–44.; Лучевая диагностика заболеваний печени (МРТ, КТ, УЗИ, ОФЭКТ и ПЭТ): руководство для врачей. Под ред. Г.Е. Труфанова. М.: ГЭОТАР-Медиа, 2007.; Тухбатуллин М.Г., Раимова Р.Ф., Зиганшина Л.Ф. и др. Значение радиоизотопной гепатосцинтиграфии для оценки функционального состояния печени при хронических диффузных заболеваниях. Мед визуал 2005;6:59–67.; Знаменский И.А. Исследование системы мононуклеарных фагоцитов радионуклидными методами у больных с заболеваниями печени и внепеченочной патологией. Автореф. дис. … докт. мед. наук. 2008.; Миронов С.П., Касаткин Ю.Н. Детская радиология. М., 1993:206 с.; Koreeda C., Kawa S.K., Takasu M. et al. A study of colloidal scintigraphy in alcoholic liver diseases: discordance from asialoscintigraphic findings. Alcohol Clin Exp Res 2000;24(Suppl 4):43–7.; Nakano H., Kumada K., Takekuma Y. et al. Perioperative hepatic functional risk assessed with technetium-99m diethylenetriamine pentaacetic acid-galactosyl human serum albumin liver scintigraphy in patients undergoing pancreaticoduo-denectomy complicated by obstructive jaundice. Int J Pancreatol 1999;25(1):3–9.; Takeuchi S., Nakano H., Kim YK. et al. Predicting survival and postoperative complications with Tc-GSA liver scintigraphy in hepatocellular carcinoma. Hepatogastroenterology 1999;46(27):1855–61.; Sakahara H., Kiuchi T., Nishizawa S. et al. Asialoglycoprotein receptor scintigraphy in evaluation of auxiliary partial orthotopic liver transplantation. J Nucl Med 1999;40(9):1463–7.; Sasaki N., Shiomi S., Iwata Y. et al. Clinical usefulness of scintigraphy with 99mTc-galactosyl-human serum albumin for prognosis of cirrhosis of the liver. J Nucl Med 1999;40(10):1652–6.; Shiomi S., Sasaki N., Tamori A. et al. Use of scintigraphy with 99m-technetium galactosyl-human serum albumin for staging of primary biliary cirrhosis and assessment of prognosis. J Gastroenterol Hepatol 1999;14(6):566–71.; Sugai Y., Komatani A., Hosoya T. et al. Response to percutaneous transhepatic portal embolization: new proposed parameters by 99mTc-GSA SPECT and their usefulness in prognostic estimation after hepatectomy. J Nucl Med 2000;41(3):421–5.; Kim J.S., Moon D.H., Lee S.G. et al. Hepatobiliary scintigraphy in the assessment of biliary obstruction after hepatic resection with biliary-enteric anastomosis. J Nucl Med 2000;27(2):170–5.; Lenzen R., Bahr A., Eichstadt H. et al. In liver transplantation, T tube bile represents total bile flow: physiological and scintigraphic studies on biliary secretion of organic anions. Liver Transpl Surg 1999;5(1):8–15.; Tanaka A., Shinohara H., Hatano E. et al. Perioperative changes in hepatic function as assessed by asialoglycoprotein receptor indices by technetium 99m galactosyl human serum albumin. Hepatogastroenterology 1999;46(25):369–75.; Радионуклидная диагностика для практических врачей. Под ред. Ю.Б. Лишманова, В.И. Чернова. Томск: STT, 2004.; Попов М.В., Галеев Ю.М., Апарцин К.А. Роль радионуклидных исследований в оценке функциональной активности аутотрансплантата ткани селезенки. Из будущего в настоящее. В сб.: Научные труды Невского радиологического форума. СПб., 2003; с. 273–4.; Silverman S., DeNardo G.L., Siegel E. Determination of spleen size by scintigraphy. Cancer Biother Radiopharm 1999;14(5):407–11.; Ajmi S., Hassine H., Essabbah H. Autotransplantation of splenic tissue after splenic injury. Scintigraphic evaluation. Clin Nucl Med 2003;28(5):402–3.; Szepes A., Bertalan V., Varkonyi T. et al. Diagnosis of gallbladder dyskinesia by quntitative hepatobiliary scintigraphy. Clin Nucl Med 2005;30(5):302–7.; Fukunaga K., Todoroki T., Takada Y. Hepatic functional reserve in patients with biliary malignancies: an assessment by technetium 99m galactosyl human serum albumin hepatic scintigraphy. Int Surg 1999;84(3):199–203.; Fujioka H., Kawashita Y., Kamohara Y. et al. Utility of technetium-99mlabeled-galactosyl-human serum albumin scintigraphy for estimating the hepatic functional reserve. J Clin Gastroenterol 1999;28(4):329–33.; Hwang E.H., Taki J., Shuke N. et al. Preoperative assessment of residual hepatic functional reserve using 99mTc-DTPAgalactosyl-human serum albumin dynamic SPECT. J Nucl Med 1999;40(10):1644–51.; Uetake M., Koizumi K., Yagawa A. et al. Use of Tc-99m DTPA galactosyl human serum albumin to predict postoperative residual liver function. Clin Nucl Med 1999;24(6):428–34.; Kira T., Tomiguchi S., Takahashi M. et al. Correlation of 99mTc-GSA hepatic scintigraphy with liver biopsies in patients with chronic active hepatitis type C. Radiat Med 1999;17(2):125–30.; Позитронная эмиссионная томография: руководство для врачей. Под ред. А.М. Гранова Л.А. Тютина. СПб.: Фолиант, 2008.; Рудас М.С., Насникова И.Ю., Матякин Г.Г. Позитронно-эмиссионная томография в клинической практике: учебнометодическое пособие. М.: Центральная клиническая больница УДП РФ, 2007.; Ширяев С.В. Эмиссионная томография в комплексной диагностике опухолевых поражений печени. Автореф. дис. … докт. мед. наук. М., 2009.; Cook G.J.R., Maisey M.N., Britton K.E. et al. Clinical Nuclear Medicine. 4 ed. London, 2006; p. 661–72.; Труфанов Г.Е., Рязанов В.В., Дергунова Н.И. и др. Совмещенная позитронноэмиссионная и компьютерная томография (ПЭТ-КТ) в онкологии. СПб.: ЭЛБИ-СПб., 2005.; Каралкин А.В., Филимонов М.И., Васильев В.Е. и др. Роль гепатобилисцинтиграфии в оценке проходимости холедоха у больных острым холециститом. Мед радиол и радиац безопас 2002;3:34–7.; Kumar R., Choudhury S., Dasan B. et al. Hepatobiliary scintigraphic findings in obstructed intrahepatic choledochal cyst before and after surgery. Clin Nucl Med 2001;26(4):331–3.; Losik SB., Studentsova Y., Dakhel M. et al. Biliary leak with normal gallbladder appearance on cholescintigraphy. Clin Nucl Med 2003;28(12):977–9.; Rajnish A., Gambhir S., Das BK. et al. Classifying Choledochal Cysts using hepatobiliary scintigraphy. Clin Nucl Med 2000;25(12):996–9.; Francois D., Walrand S., Nieuwenhuyse J.P.V. et al. Hepatobiliary scintigraphy in a patient with bilhemia. Eur J Nucl Med 1994;20(12):1020–3.; Yong M.L., Joyce J.M., Weinberg L.M. et al. Biliary pleural fistula detected by hepatobiliary scintigraphy. Clin Nucl Med 2005;30(4):281–3.; Zeon S.K., Ryu J.G., Kim S. et al. Incidentally detected intestinal malrotation on hepatobiliary scan in a patient with bile duct injury. Clin Nucl Med 1997;17(8):533–5.; Blum M., Fiedler C., Winde G. et al. Die bilhamie – ein uberblick uber diagnostik und therapie. Chirurg 1987;58(7):482–6.; Brown R.D., Zanzi I., Harris G. et al. Gallbladder perforation and hepatobiliary scintigraphy. Clin Nucl Med 2004;29(10):644–5.; Young T.-H., Chao Y.-C., Tang H.- S. et al. Choledocho-trasverse colon fistula seen with hepatobiliary imaging. Clin Nucl Med 1996;21(4):323–5.; Koranda P., Myslivecek M., Erban J. et al. Hepatic perfusion changes in patients with cirrhosis indices of hepatic arterial blood flow. Clin Nucl Med 1999;24(7):507–10.; Kato H., Kaito M., Gabazza E.C. et al. Assessment of portosystemic shunt by summation of radioactivity during 201-thallium chloride portal scintigraphy in patients with chronic liver disease. Hepatogastroenterology 2000;47(33):672–7.; Shiomi S., Iwata Y., Sasaki N. et al. Clinical need for both scintigraphy with technetium-99m GSA and per-rectal portal scintigraphy in some patients with chronic liver disease. Ann Nucl Med 1999;13(4):241–5.; Shiomi S., Sasaki N., Ikeoka N. et al. Usefulness of per-rectal portal scintigraphy with Tc-99m pertechnetate for galactosemia in infants. Ann Nucl Med 1998;12(6):375–8.; Герасимова Н.П., Комарова Н.Л., Смирнов И.Е. и др. Диагностические возможности динамической сцинтиграфии при патологии почек у детей. В сб.: Мат-лы 2-го Всероссийского национального конгресса по лучевой диагностике и терапии. М., 2008; с. 68–9.; Ищенко Б.И., Громов А.И. Лучевое обследование больных с синдромом почечной колики: методическое пособие. СПб.: Элби-СПб., 2006.; Знаменский И.А., Бышов А.А., Томашевский И.О. и др. Определение стадии хронической почечной недостаточности радионуклидными методами. В сб.: Матлы 2-го Всероссийского национального конгресса по лучевой диагностике и терапии. М., 2008; с. 104–5.; Лишманов Ю.Б., Веснина Ж.В., Гуляев А.М. и др. Радионуклидная реносцинтиграфия в оценке нефротоксического действия рентгеноконтрастных веществ. В сб.: Научные труды Всероссийского конгресса лучевых диагностов. М., 2007; с. 209–10.; Смирнов Ю.Н., Фомин Д.К., Яцык С.П. и др. Радионуклидные методы исследований в детской уронефрологии. Медицинская физика–2005. В сб.: Научные труды II Евразийского конгресса по медицинской физике и инженерии. М., 2005.; с. 166.; Фомин Д.К. Диагностика обструктивных уропатий у детей методами ядерной медицины. Автореф. дис. … докт. мед. наук. М., 2009.; Murthy R., Chahal M., Appel G. et al. Exercise acutely increases renal transit time of Tc-99m mercapto-acetyltriglycine (MAG-3) in a post-liver transplant patient. Clin Nucl Med 2006;31(12):829–34.; Fonseca R.B., Duarte P.S., Susuki L. Vesicoureteral reflux in patient with complete ureteral duplication detected on Tc99v DTPA renography. Clin Nucl Med 2003;28(6):498–500.; Терехов В.И. Диагностическая значимость однофотонной эмиссионной компьютерной томографии при гидронефротической трансформации. В сб.: Мат-лы 2-го Всероссийского национального конгресса по лучевой диагностике и терапии. М., 2008; с. 283.; Давыдов Г.А., Ефимов О.Н., Карякин О.Б. и др. Методика исследования функции почек при сцинтиграфии с 99mТс-технефором у онкоурологических больных. Радиология. 2006; В сб.: Научные труды VII Всероссийского научного форума. М., 2006; с. 65–6.; Смолярчук М.Я., Давыдов Г.А., Ефимов О.Н. и др. Радионуклидные исследования в изучении функции почек и диагностике метастатических поражений скелета у онкоурологических больных. В сб.: Мат-лы 2-го Всероссийского национального конгресса по лучевой диагностике и терапии. М., 2008; с. 268–9.; https://www.jtransplantologiya.ru/jour/article/view/263

الاتاحة: https://www.jtransplantologiya.ru/jour/article/view/263
https://doi.org/10.23873/2074-0506-2010-0-1-5-10

المؤلفون: M. Khubutia Sh., A. Chuchalin G., M. Abakumov M., S. Avdeev N., V. Timerbaev Kh., I. Poplavsky V., M. Godkov A., M. Minina G., E. Tarabrin A., N. Karchevskaya A., S. Golovinsky V., N. Levitskaya N., V. Gulyaev A., N. Meshcheryakova N., M. Samsonova V., V. Polishchuk B., D. Ibragimova F., D. Tsurova Kh., I. Selina E., I. Popova E., М. Хубутия Ш., А. Чучалин Г., М. Абакумов М., С. Авдеев Н., В. Тимербаев Х., И. Поплавский В., М. Годков А., М. Минина Г., Е. Тарабрин А., Н. Карчевская А., С. Головинский В., Н. Левицкая Н., В. Гуляев А., Н. Мещерякова Н., М. Самсонова В., В. Полищук Б., Д. Ибрагимова Ф., Д. Цурова Х., И. Селина Е., И. Попова Е.

المصدر: Transplantologiya. The Russian Journal of Transplantation; № 2-3 (2011); 5-9 ; Трансплантология; № 2-3 (2011); 5-9 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2011-0-2-3

مصطلحات موضوعية: lung transplantation, lymphangioleiomyomatosis, трансплантация легких, лимфангиолейомиоматоз

وصف الملف: application/pdf

Relation: https://www.jtransplantologiya.ru/jour/article/view/328/389; Christie J.D., Edwards L.B., Kucheryavaya A.Y.et al. The Registry of the International Society for Heartand Lung Transplantation: Twenty-eighth Adult Lung and Heart-Lung Transplant Report–2011. J Heart Lung Transplant 2011;30(10):1104–22.; Готье С.В., Мойсюк Я.Г., Хомяков С.М., Ибрагимова О.С. Развитие органного донорства и трансплантации в Российской Федерации в 2006–2010 годах. III сообщение регистра Российского трансплантологического общества. Вестн трансплант и искусств органов 2011;13(2):6–20.; Закон Российской Федерации о трансплантации органов и (или) тканей человека № 4180-1 от 22 декабря 1992 г.; Bhorade S.M., Vigneswara W., McCabe M.A., Garrity E.R. Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation. J Heart Lung Transplant 2000;19:1199.; Демихов В.П. Гомопластическая пересадка сердца и легких у теплокровных (собак). Труды Первой всесоюзной конференции по грудной хирургии 14–21/V 1947 г. Москва. В кн.: Вопросы грудной хирургии. М.: Медгиз, 1949; с.42–6.; Hardy J.D., Webb W.R., Dalton M.L.Jr., Walker G.R.Jr. Lung homotransplantations in man. JAMA 1963;186:1065–74.; Orens J.B., Estenne M., Arcasoy S. et al. International guidelines for the selection of lung transplant candidates: 2006 update – a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006;25(7):745–55.; https://www.jtransplantologiya.ru/jour/article/view/328

الاتاحة: https://www.jtransplantologiya.ru/jour/article/view/328
https://doi.org/10.23873/2074-0506-2011-0-2-3-5-9

المؤلفون: M. Khubutia Sh., S. Zhuravel V., N. Kuznetsova K., I. Alexandrova V., М. Хубутия Ш., С. Журавель В., Н. Кузнецова К., И. Александрова В.

المصدر: Transplantologiya. The Russian Journal of Transplantation; № 1 (2013); 24-27 ; Трансплантология; № 1 (2013); 24-27 ; 2542-0909 ; 2074-0506 ; undefined

مصطلحات موضوعية: Liver transplantation, critical state, fungal infection, трансплантация печени, критическое состояние, грибковая инфекция

وصف الملف: application/pdf

Relation: https://www.jtransplantologiya.ru/jour/article/view/4/5; Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions / W. Laleman [et al.] // Expert Rev Gastroenterol Hepatol. – 2011. – Vol. 5. – № 4. – P. 523–537.; Olson, J.C. Acute-on-chronic liver failure: concept, natural history, and prognosis / J.C. Olson, P.S. Kamath // Curr Opin Crit Care. – Vol. 17. – № 2. – P. 165–169.; Прогнозирование и трансплантация печени при острой печеночной недостаточности / С.В. Журавель [и др.] // Consilium medicum=Хирургия. – 2005. – Т. 7. – Приложение № 1. – С. 80–82.; Review article: non-biological liver support in liver failure / W. Laleman [et al.] // Aliment Pharmacol Ther. – 2006. – Vol. 23. – № 3. – P. 351–363.; Jalan, R. Acute-on-chronic liver failure: pathophysiological basis of therapeutic options / R. Jalan, R. Williams // Blood Purif. – 2002. – Vol. 20. – № 3. – P. 252–261.; Desmet, V.J. Cirrhosis reversal: a duel between dogma and myth / V.J. Desmet, T. Roskams // J Hepatol. – 2004. – Vol. 40. – № 5. – P. 860–867.; Warrilow, S.J. Predictions and outcomes for the critically ill patient with cirrhosis: is it time to settle on the SOFA and let jaundiced views on the outcome MELD away / S.J. Warrilow // Crit Care Med. – 2010. – Vol. 38. – № 11. – P. 59–2260.; Cirrhotic patients in the medical intensive care unit: early prognosis and long-term survival / V. Das [et al.] // Crit Care Med. – 2010. – Vol. 38. – № 11. – P.108–2116.; Liver transplantation in the critically ill: a multi-centre Canadian retrospective cohort study / C.J. Karvellas [et al.] // Critical Care. – 2013. – Vol. 17. – № 1. – P. 28.; Журавель, С.В. Проблема системного кандидоза после трансплантации солидных органов / С.В. Журавель, А.О. Чугунов, Т.В. Черненькая // Трансплантология. – 2012. – № 3. – С. 42–48.; https://www.jtransplantologiya.ru/jour/article/view/4; undefined

الاتاحة: https://www.jtransplantologiya.ru/jour/article/view/4

المؤلفون: M. Khubutia Sh, V. Sjutkin E., N. Kuznetsova K., S. Zhuravel V., M. Novruzbekov S., М. М.Ш. Хубутия, Ш., В. Сюткин Е., Н. Кузнецова К., С. Журавель В., М. Новрузбеков С.

المصدر: Transplantologiya. The Russian Journal of Transplantation; № 2 (2013); 23-27 ; Трансплантология; № 2 (2013); 23-27 ; 2542-0909 ; 2074-0506 ; undefined

مصطلحات موضوعية: liver transplantation, immunosuppressive therapy, inhibitors mTOR, трансплантация печени, иммуносупрессивная терапия, ингибиторы mTOR

وصف الملف: application/pdf

Relation: https://www.jtransplantologiya.ru/jour/article/view/13/14; Calcineurin inhibitor minimization protocols in liver transplantation / S.A. Farkas [et al.] // Transpl Int. – 2009. – Vol. 22. – N1. – P. 49–60.; Fung, J. Rapamycin: friend, foe, or misunderstood? / J. Fung, A. Marcos // Liver Transpl. – 2003. – Vol. 9. – N5. – P. 469–472.; A Decade of Experience Using mTor Inhibitors in Liver Transplantation / J. Campsen [et al.] // J Transplant. – 2011. – doi:10.1155/2011/913094.; Chronic renal failure after transplantation of a nonrenal organ / A.O. Ojo [et al.] // N Engl J Med. – 2003. – Vol. 349. – N 10. – P. 931–940.; Long-term renal function in liver transplant recipients and impact of immunosuppressive regimens (calcineurin inhibitors alone or in combination with mycophenolate mofetil): the TRY study / S. Karie-Guigues [et al.] // Liver Transpl. – 2009. – Vol. 15. – N9. – P. 1083–1091.; Conversion to everolimus monotherapy in maintenance liver transplantation: feasibility, safety, and impact on renal function / P. De Simone [et al.] // Transpl Int. – 2009. – Vol. 22. – N 3. – P. 279–286.; Rescue immunosuppression with mammalian target of rapamycin inhibitor drugs in liver transplantation / J.M. Martinez et al. // Transplant Proc. – 2010. – P. 42. – N 2. – P. 641–643.; Sirolimus conversion regimen versus continued calcineurin inhibitors in liver allograft recipients: a randomized trial / M.F. Abdelmalek [et al.] // Am J Transplant. – 2012. – Vol. 12. – N 3. Р – 694–705.; Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: a prospective, randomized, multicenter trial / P. De Simone [et al.] // Liver Transpl. – 2009. – Vol. 15. – N 10. – P. 1262–1269.; Early withdrawal of calcineurin inhibitors and everolimus monotherapy in de novo liver transplant recipients preserves renal function / M. Masetti [et al.] // Am J Transplant. – 2010. – Vol. 10. – N 10. – P. 2252–2262.; Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial / P. De Simone [et al.] // Am J Transplant. – 2012. – Vol. 12. – N 11. – P. 3008–3020.; A randomized, controlled study to assess the conversion from calcineurininhibitors to everolimus after liver transplantationPROTECT / L. Fischer [et al.] // Am J Transplant. – 2012. – Vol. 12. – N 7. – P. 1855–1865.; Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12- and 36-month results / G. Levy [et al.] // Liver Transpl. – 2006. – Vol. 12. – N 11. – P. 1640–1648.; Conversion to everolimus in maintenance liver transplant patients: a multicenter, retrospective analysis / F. Saliba [et al.] // Liver Transpl. – 2011. – Vol. 17. – N 8. – P. 905–913.; https://www.jtransplantologiya.ru/jour/article/view/13; undefined

الاتاحة: https://www.jtransplantologiya.ru/jour/article/view/13